Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
6
×
national blog main
san francisco blog main
6
×
startups
6
×
boston blog main
boston top stories
deals
national top stories
new york blog main
vc
san diego blog main
software
biotech
boston
healthcare
healthtech
new york top stories
roboticsai
san francisco top stories
fda
medical devices
mobile
raleigh-durham blog main
san diego top stories
san francisco
seattle blog main
tech
wisconsin blog main
wisconsin top stories
4490 ventures
accelerator
acetylon pharmaceuticals
agro biosciences
agtech products
agtechfood
airbnb
amazon web services (aws)
ambys medicines
andreessen horowitz
apps
What
startup
6
×
new
approach
big
biotech
called
developing
healthcare
medicines
million
years
admits
ago
aiming
aims
ambys
andreessen
answer
based
beta
bigger
bionics
biotechs
blood
classes
closed
combinator
companies
control
deadly
deal
deals
debuted
debuts
device
devoted
diabetes
diseases
driven
drugs
Language
unset
Current search:
startups
×
startup
×
" san francisco blog main "
×
" life sciences "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?